ARQT - Arcutis Biotherapeutics Q4 results beat estimates February, 28 2023 05:10 PM Arcutis Biotherapeutics Inc. Arcutis Biotherapeutics press release ( NASDAQ: ARQT ): Q4 GAAP EPS of -$1.18 beats by $0.27 . Revenue of $2.96M beats by $0.91M . For further details see: Arcutis Biotherapeutics Q4 results beat estimates